Literature DB >> 7558622

Abnormal peripheral microcirculation in seemingly normal subjects living in blackfoot-disease-hyperendemic villages in Taiwan.

C H Tseng1, C K Chong, C J Chen, B J Lin, T Y Tai.   

Abstract

Blackfoot disease (BFD) is an endemic peripheral arterial disease confined to the southwestern coast of Taiwan. The cause of the disease has been ascribed to the high-arsenic artesian well water. The purpose of this study was to examine the possible association between the long-term exposure to artesian well water and the change in microvascular circulation in the absence of peripheral arterial insufficiency. A total of 45 men living in the BFD-hyperendemic villages and another 51 age- sex- body-mass index-matched men who lived in nonendemic villages nearby were recruited into this study. All subjects were free from peripheral vascular disease (resting ankle-brachial index > 1.00), clinical claudication, cigarette smoking, diabetes mellitus, hypertension, ischemic heart disease, cerebral infarction and obesity. Laser Doppler flowmetry was used to measure the peripheral microcirculation on the big toes both at 36 degrees C (basal perfusion, Pb) and after a hyperthermic test at 42 degrees C (Ph). The time required to reach Ph (T), and the average rate (R) of increase from Pb to Ph measured by (Ph-Pb)/T were also calculated. Results showed that those living in the BFD-hyperendemic area had a lower Pb [32.8 +/- 6.0 perfusion units (PU) vs. 67.0 +/- 4.3 PU, p < 0.001], a lower Ph (193.2 +/- 13.6 vs. 231.1 +/- 6.3 PU, p < 0.005), a longer T (3.04 +/- 0.19 vs. 1.31 +/- 0.08 min, p < 0.001) and a slower rate of increase from Pb to Ph (48.0 +/- 4.8 vs. 76.2 +/- 5.4 PU/min, p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558622     DOI: 10.1159/000178945

Source DB:  PubMed          Journal:  Int J Microcirc Clin Exp        ISSN: 0167-6865


  8 in total

1.  Red blood cell tracking using optical flow methods.

Authors:  Dongmin Guo; Anne L van de Ven; Xiaobo Zhou
Journal:  IEEE J Biomed Health Inform       Date:  2013-09-16       Impact factor: 5.772

2.  Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes.

Authors:  David S Paul; Araceli Hernández-Zavala; Felecia S Walton; Blakely M Adair; Jirí Dedina; Tomás Matousek; Miroslav Stýblo
Journal:  Toxicol Appl Pharmacol       Date:  2007-01-30       Impact factor: 4.219

3.  Probabilistic framework for assessing the arsenic exposure risk from cooked fish consumption.

Authors:  Min-Pei Ling; Chiu-Hua Wu; Szu-Chieh Chen; Wei-Yu Chen; Chia-Pin Chio; Yi-Hsien Cheng; Chung-Min Liao
Journal:  Environ Geochem Health       Date:  2014-05-08       Impact factor: 4.609

4.  Inorganic arsenite potentiates vasoconstriction through calcium sensitization in vascular smooth muscle.

Authors:  Moo-Yeol Lee; Young-Ho Lee; Kyung-Min Lim; Seung-Min Chung; Ok-Nam Bae; Heon Kim; Choong-Ryeol Lee; Jung-Duck Park; Jin-Ho Chung
Journal:  Environ Health Perspect       Date:  2005-10       Impact factor: 9.031

5.  Excretion of arsenic in urine as a function of exposure to arsenic in drinking water.

Authors:  R L Calderon; E Hudgens; X C Le; D Schreinemachers; D J Thomas
Journal:  Environ Health Perspect       Date:  1999-08       Impact factor: 9.031

6.  Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.

Authors:  C H Hsu; S A Yang; J Y Wang; H S Yu; S R Lin
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

7.  Earth Abides Arsenic Biotransformations.

Authors:  Yong-Guan Zhu; Masafumi Yoshinaga; Fang-Jie Zhao; Barry P Rosen
Journal:  Annu Rev Earth Planet Sci       Date:  2014-03-03       Impact factor: 12.810

8.  Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects.

Authors:  Meei-Maan Wu; Hung-Yi Chiou; I-Ching Ho; Chien-Jen Chen; Te-Chang Lee
Journal:  Environ Health Perspect       Date:  2003-08       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.